Jagsonpal Pharmaceuticals Limited
Balance Sheet
Last updated:
The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Jagsonpal Pharmaceuticals Limited's balance sheet done over the years? Its assets were worth $2,170,780,000 last year, which is more than in the previous period. 14% of Jagsonpal Pharmaceuticals Limited’s total assets is currently financed by debt. Its liabilities reached the amount of $296,760,000, which means an decrease by -21% compared compared to last year.
Debt to Assets
| 2011 | 1367181024 | 438.04M | 32.04% |
|---|---|---|---|
| 2012 | 1560995000 | 576.30M | 36.92% |
| 2015 | 1542200000 | 587.94M | 38.12% |
| 2016 | 1592818000 | 609.17M | 38.24% |
| 2018 | 1298148000 | 317.68M | 24.47% |
| 2019 | 1357841000 | 313.11M | 23.06% |
| 2020 | 1469549000 | 359.21M | 24.44% |
| 2021 | 1642024000 | 422.73M | 25.74% |
| 2022 | 1684547000 | 375.99M | 22.32% |
| 2024 | 2170780000 | 296.76M | 13.67% |
JAGSNPHARM.NS Balance Sheet (2011 – 2023)
| 2023 | 2021 | 2020 | 2019 | 2018 | 2017 | 2015 | 2014 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets: | ||||||||||
Cash and cash equivalents | 127.6M | 251.35M | 586.31M | 380.74M | 385.34M | 145.12M | 155.33M | 150.16M | 98.80M | 73.25M |
Short term investments | 4.7M | 221.41M | 32.50M | 0 | 309.54M | 78.75M | 0 | 0 | 0 | 0 |
Net receivables | 0 | 337.66M | 288.47M | 266.18M | 253.91M | 256.37M | 416.90M | 448.88M | 0 | 0 |
Inventory | 149.97M | 297.42M | 297.24M | 293.25M | 326.92M | 514.33M | 398.37M | 330.62M | 352.16M | 225.53M |
Other current assets | 363.23M | -81K | 228K | 8.92M | 9.40M | 35.13M | 38.97M | 28.26M | 458.33M | 491.55M |
Total current assets | 1.99B | 1.10B | 1.20B | 949.10M | 975.58M | 946.13M | 1.00B | 957.93M | 909.30M | 790.34M |
Non-current assets: | ||||||||||
Property, Plant and Equipment | 93.02M | 223.72M | 233.46M | 239.63M | 235.05M | 222.66M | 515.84M | 519.30M | 600.47M | 576.52M |
Goodwill | 0 | 300K | 300K | 300K | 300K | 300K | 300K | 300K | 0 | 0 |
Intangible assets | 0 | 23.45M | 23.45M | 23.45M | 20.62M | 20.62M | 300K | 0 | 0 | 0 |
Long term investments | 47M | 290.55M | 120.58M | 113.86M | 5K | 5K | 5K | 5K | 0 | 0 |
Other non-current assets | 38.22M | 29.22M | 38.34M | -353.80M | -2K | 108.42M | 67.09M | 64.66M | 51.21M | 5.03K |
Total non-current assets | 178.24M | 576.77M | 437.25M | 520.44M | 382.25M | 352.01M | 583.23M | 584.27M | 651.69M | 576.83M |
Total assets | 2.17B | 1.68B | 1.64B | 1.46B | 1.35B | 1.29B | 1.59B | 1.54B | 1.56B | 1.36B |
Liabilities | ||||||||||
| Current liabilities: | ||||||||||
Accounts payable | ||||||||||
Deferred revenue | 12.94M | 0 | 137.48M | 92.07M | 80.72M | 0 | 24.76M | 17.67M | 0 | 0 |
Short term debt | 13.84M | 0 | 67.87M | 46.64M | 37.85M | 83.00M | 384.92M | 393.10M | 346.23M | 0 |
Total current liabilities | 191.28M | 341.55M | 403.96M | 328.29M | 281.91M | 285.83M | 573.08M | 551.91M | 533.77M | 118.42M |
| Non-current liabilities: | ||||||||||
Long term debt | 75.57M | 0 | 180K | 0 | 0 | 0 | 0 | 0 | 2.70M | 285.93M |
Deferred tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 33.67M |
Other non-current liabilities | 29.91M | 12.56M | 37.35M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total non-current liabilities | 105.48M | 34.43M | 18.76M | 30.91M | 31.19M | 31.85M | 36.08M | 36.02M | 42.53M | 319.61M |
Total liabilities | 296.76M | 375.99M | 422.73M | 359.21M | 313.11M | 317.68M | 609.17M | 587.94M | 576.30M | 438.04M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |